This stops the activation in the T-cell which Generally would target and destroy cancer. The cancer cells can then multiply and distribute. When Keytruda binds into the PD-one receptor it stops cancer cells from linking to and inactivating T-cells, allowing for T-cell re-activation, and boosting the